Showing results (671-680 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|March 22, 2003
IL-12: a promising adjuvant for cancer vaccinationJohanna E A Portielje, Jan Willem Gratama, Heidi H van Ojik, et al.Cancer Immunology, Immunotherapy : CII|March 22, 2003
Induction of cellular immunity by anti-idiotypic antibodies mimicking GD2 gangliosideSaroj Basak, Brigitte Birebent, Enkhtsetseg Purev, et al.Cancer Immunology, Immunotherapy : CII|March 22, 2003
Cryopreservation of mature monocyte-derived human dendritic cells for vaccination: influence on phenotype and functional propertiesJörg Westermann, Ida J Körner, Joachim Kopp, et al.Cancer Immunology, Immunotherapy : CII|April 2, 2003
A phase 2 study of the cytotoxic immunoconjugate CMB-401 (hCTM01-calicheamicin) in patients with platinum-sensitive recurrent epithelial ovarian carcinomaStephen Y Chan, Alan N Gordon, Robert E Coleman, et al.Cancer Immunology, Immunotherapy : CII|April 2, 2003
Bcl-2 expression in metastatic malignant melanoma. Importance for the therapeutic efficacy of biochemotherapyAnnika Håkansson, Bertil Gustafsson, Avni Abdiu, et al.Cancer Immunology, Immunotherapy : CII|June 13, 2003
The effects of alphaGalCer-induced TCRValpha24 Vbeta11(+) natural killer T cells on NK cell cytotoxicity in umbilical cord bloodYoko Ueda, Masao Hagihara, Balgansuren Gansuvd, et al.Cancer Immunology, Immunotherapy : CII|June 18, 2003
Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patientsL G Durrant, M A Chapman, D J Buckley, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1992
Detection of allogeneic Qa/TL and Ly specificities on murine tumor cells with IgD in tumor-regressor serumT Tanino, N Seo, T Okazaki, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1992
Enhancement of rat hepatic macrophages by treatment with interleukin-2 and streptococcal preparation OK432, with reference to antitumor activity, soluble factor production and Ia expressionT Sasaoki, S Arii, K Monden, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1992
Monoclonal antibodies anti-CD3, anti-TCR alpha beta and anti-CD2 act synergistically with tumor cells to stimulate lymphokine-activated killer cells and tumor-infiltrating lymphocytes to secrete interferon gammaA S Chong, E D Staren, P ScuderiPageof 650